Przegląd Dermatologiczny
facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
6/2025
vol. 112
 
Poleć ten artykuł:
Udostępnij:
Opis przypadku

Not obvious manifestation of extragenital lichen sclerosus in a child: a case report and literature review

Julia Woźna
1
,
Nina Łabędź
1
,
Monika Bowszyc-Dmochowska
2
,
Aleksandra Dańczak-Pazdrowska
1
,
Adriana Polańska
1

  1. Department of Dermatology and Venereology, Poznan University of Medical Sciences, Poznan, Poland
  2. Department of Dermatology, Cutaneous Histopathology and Immunopathology Section, Poznan University of Medical Sciences, Poznan, Poland
Dermatol Rev/Przegl Dermatol 2025, 112, 373-377
Data publikacji online: 2026/02/28
Plik artykułu:
- Not Obvious - Wozna.pdf  [1.54 MB]
Pobierz cytowanie
 
Metryki PlumX:
 

INTRODUCTION

Lichen sclerosus (LS) is a chronic inflammatory skin condition of uncertain aetiology that most commonly affects the genital area in individuals of all genders, with a notably higher occurrence in postmenopausal women and young girls before puberty. Approximately 85% of LS cases are confined to the genital region, while extragenital involvement is uncommon, occurring in about 15–20% of cases [1]. The clinical manifestations of vulvar LS, especially in girls, usually include porcelain-white atrophic plaques, sometimes with a figure of eight or hourglass configuration involving both the vulva and perianal area [2]. Extragenital lichen sclerosus (EGLS) typically presents as asymptomatic, porcelain-white, atrophic plaques that may coalesce into larger areas of sclerotic skin. These lesions are frequently located on the upper trunk, neck, shoulders, and proximal extremities. Less commonly, EGLS can involve atypical sites such as the breasts, face, and acral areas, including the hands and feet [3]. LS is frequently associated with other autoimmune diseases. Studies have shown a higher prevalence of thyroid disorders (especially Hashimoto’s thyroiditis), vitiligo, alopecia areata, and pernicious anaemia in patients with LS. This comorbidity is observed in both paediatric and adult populations, suggesting a potential shared immunopathogenic mechanism [4]. This report describes the case of an 11-year-old girl diagnosed with genital and extragenital lichen sclerosus involving the palms and feet, with concurrent vitiligo.

OBJECTIVE

The aim of this case presentation is to highlight the importance of recognizing atypical presentations of LS in pediatric patients and the need for comprehensive evaluation when autoimmune skin disorders coexist. In addition to the case description, a brief review of the literature on previously reported cases of palmar LS is provided, offering comparative clinical insights and emphasizing the rarity of such manifestations in children.

CASE REPORT

An 11-year-old girl presented to the dermatology outpatient clinic with a 4-year history of asymptomatic hypopigmented patches in the vulvar area. Approximately 2 years after the onset of the vulvar lesions, additional hypopigmented patches appeared on the palms (Figures 1 A, B), wrists, heels, and ankles, along with typical vitiligo patches on the eyelids. Small, brown macules on a depigmented background were also observed on the forearms and ankles. Based on the initial vulvar involvement, a diagnosis of LS was made. However, the subsequent development of widespread lesions raised suspicion of an alternative or coexisting dermatologic condition. A skin biopsy was taken from the lesion in the ankle area, and the histopathological findings were most consistent with LS (Figures 2 A, B). The patient was initially treated with topical clobetasol, followed by maintenance therapy with topical tacrolimus, targeting the vulvar LS. The lesions on the palms, heels, and ankles were treated with topical clobetasol and a topical calcineurin inhibitor with no significant improvement. Notably, the vitiligo patches on the eyelids showed improvement with treatment by the topical calcineurin inhibitor and eventually resolved completely.

Figure 1

A, B – Clinical presentation of hypopigmented patches on the palms with prominent acrosyryngia in a 11-year-old girl

/f/fulltexts/PD/56587/PD-112-56587-g001_min.jpg
Figure 2

Magnification: 4× (A) and 10× (B). The epidermis is thin with flattened rete ridges and a thickened stratum corneum. The underlying connective tissue stroma appears subtly homogenized, with no inflammatory infiltrates. These histopathological features are not fully representative for lichen sclerosus and morphea

/f/fulltexts/PD/56587/PD-112-56587-g002_min.jpg

DISCUSSION

LS is well characterized in adults, but data on its presentation in children are still limited [5]. In paediatric cases, particularly among girls, LS most frequently affects the anogenital area, with approximately 94.6% presenting lesions in this region. Only 5.4% exhibit either isolated extragenital lesions or a combination of genital and extragenital involvement [6]. Characteristic findings of genital LS in girls encompass porcelain-white, atrophic plaques arranged in a “figure-eight” pattern involving the vulva and perianal area. Advanced cases may exhibit fissures, erosions, scarring, and architectural changes such as labial fusion or clitoral phimosis [7]. Common extragenital sites include the trunk, neck, shoulders, and upper limbs. While LS itself is already considered a rare condition, its manifestation on the palms and feet is exceptionally uncommon. To date, only a few cases involving lesions on the palms or hands have been reported in the literature, with varying clinical presentations. Among them, Purres and Krull [8] and Petrozzi et al. [9] describe cases that are clinically similar. Notably, none of these cases have involved paediatric patients (Table 1) [816].

Table 1

Extragenital LS cases with palmar involvement

AuthorsAge/sexGenital involvementDistributionClinical presentation
Steff et al. [10]56 FYesDorsal feet, phalanges, palms, soles, genital areaIvory-white papules on dorsal feet and distal phalanges; keratotic, centrally depressed papules in palmar creases; erythema of soles and thenar/hypothenar eminences
de Viana et al. [11]57 FYesSoles, palms, paranasal sinuses perigenital areaGrouped hypopigmented papules and plaques, later extension to perigenital area
Herz-Ruelas et al. [12]60 FNoPalms, anterior wrists, soles, trunk, lower extremitiesSclerotic plaques with a shiny/wrinkled surface on body lesions and soles. Small coalescing bullae noticeable upon palpation’; disabling pain on standing and walking
Seyffert et al. [13]69 MNoPalms, arms, dorsal fingers, wrists, trunk, thighsErythematous, ivory, hyperpigmented atrophic plaques ranging in size from 0.5 cm to 4 cm on the proximal extremities and trunk; diffuse erythema with atrophic and bullous ivory-yellow plaques on palms with dermatoglyphic and eccrine ostia accentuation extending onto the flexural wrist
Sánchez-Mateos et al. [14]71 FYesDorsal hands, palms, wrists, fingers, genital areaPale-yellow, firm waxy plaques evolving into pseudobullous, atrophic lesions on hands; nail ridging; vulvar pain and whitening
Purres and Krull [8]71 FYesBoth palms, upper back, chest, shoulders, forearms, genital areaAtrophic white papules and plaques on palms with keratotic plugs; widespread white plaques on trunk and forearms, some with follicular plugs; vulvar atrophy and whitening
Heibel et al. [15]67 FNoPalms, wrists, toe webs, sides of feet and toesMultiple, white, hyperkeratotic papules pain and soreness while walking and during palpation; no pruritus
Petrozzi et al. [9]57 FNoSoles and palmsMultiple white papules on soles and few depressed, slightly keratotic papules in central palms; pain when walking
Aggarwal et al. [16]58 MNoDorsal hands, palms, soles, dorsal feet, wristsHypopigmented to depigmented guttate macular lesions, polygonal, well-defined, atrophic lesions with wrinkled surface; Koebner phenomenon and erythematous halo on dorsal hands

Although LS can be asymptomatic, common symptoms in children include pruritus, pain, dysuria, constipation, and burning sensations in the anogenital area [6]. Behavioural changes may also occur, often driven by persistent discomfort and the child’s desire for attention and support from caregivers [17, 18]. Due to its rarity and nonspecific presentation, EGLS in children can be misdiagnosed, underscoring the importance of considering LS in the differential diagnosis of paediatric patients presenting with such lesions [19, 20].

LS is commonly associated with a variety of autoimmune conditions, including vitiligo vulgaris, alopecia areata, type 1 diabetes mellitus, thyroid dysfunction (especially Graves’ disease), atopic dermatitis, psoriasis, polymyalgia rheumatica, lupus panniculitis, primary biliary cirrhosis, myositis, systemic lupus erythematosus, and pernicious anemia [21]. A recent comprehensive study involving 744 female patients with vulvar LS revealed that 24.5% of children and 34.6% of adults had concurrent autoimmune diseases. The most prevalent autoimmune conditions identified were psoriasis, Hashimoto’s thyroiditis, lichen planus, and vitiligo [4]. Genetic studies have identified associations between LS and the HLA class II locus DQ7, particularly in women, suggesting a genetic predisposition to both LS and other autoimmune disorders. A study of 30 female children with vulvar LS demonstrated that 66% were positive for HLA DQ7, a genetic marker associated with autoimmune diseases. Furthermore, 56% of their parents or grandparents had a history of autoimmune diseases, indicating a strong familial predisposition [22].

In this case, the patient also presented with vitiligo, further complicating the diagnostic process. Vulvar LS and vulvar vitiligo share similar clinical presentations, both characterized by white macules and patches, posing a diagnostic challenge for clinicians. In paediatric patients with LS, especially girls, petechiae may be common in this region [23]. However, in cases where clinical features are atypical for LS and petechiae are present, the possibility of sexual abuse should be carefully considered and appropriately evaluated as part of the differential diagnosis [24]. In uncertain cases, a biopsy is recommended. Histopathological features of LS may vary depending on the stage of the disease and can overlap with other dermatoses [25, 26].

In early LS, both clinical and histological features may be nonspecific. Histology often reveals subtle changes such as hyperkeratosis, hypergranulosis of adnexal structures, mild irregular acanthosis, focal thickening of the basement membrane, and subepithelial oedema with homogenized collagen and dilated vessels. A lymphocytic infiltrate – lichenoid or interstitial – may be present, along with epidermal exocytosis and occasional lymphocytic vasculitis. In chronic lesions, classic findings include epidermal atrophy with flattened rete ridges, vacuolar interface changes, dermal hyalinization, loss of elastic fibres, and a band-like lymphocytic infiltrate. Notably, prominent acanthosis can still appear, particularly in vulvar LS [27, 28].

Differentiating LS from vitiligo can be facilitated by histochemical and immunohistochemical staining [29]. Fontana-Masson staining assesses melanin content, while immunohistochemical markers such as Melan-A, MITF, tyrosinase, and NKI/beteb evaluate melanocyte presence and activity [30]. Among these, tyrosinase staining demonstrated the most significant difference in melanocyte activity between LS and vitiligo, highlighting its diagnostic value [30].

CONCLUSIONS

The coexistence of these conditions underscores the importance of careful clinical, histopathological, and therapeutic assessment in paediatric dermatology as their overlapping features may considerably complicate the diagnostic process.

ACKNOWLEDGMENTS

Julia Woźna and Nina Łabędź contributed equally.

ETHICAL APPROVAL

Not applicable.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

References

1 

Powell J.J., Wojnarowska F.: Lichen sclerosus. Lancet 1999, 353, 1777-1783.

2 

Liu L., He Y., Hu Q., Sun K., Yang M., Chang J.: Vulvar lichen sclerosus in girls and adult females: a single-center retrospective study of 744 patients in China. J Dermatol 2024, 51, 1470-1475.

3 

Arif T., Fatima R., Sami M.: Extragenital lichen sclerosus: a comprehensive review. Australas J Dermatol 2022, 63, 452-462.

4 

Guttentag A., Wijaya M., Fischer G.O., Lee A., Liu K., Saunderson R.B.: A guide to screening for autoimmune diseases in patients with vulvar lichen sclerosus. Australas J Dermatol 2025, 66, 135-141.

5 

Kumar K.S., Morrel B., van Hees C.L.M., van der Toorn F., van Dorp W., Mendels E.J.: Comparison of lichen sclerosus in boys and girls: a systematic literature review of epidemiology, symptoms, genetic background, risk factors, treatment, and prognosis. Pediatr Dermatol 2022, 39, 400-408.

6 

Balakirski G., Grothaus J., Altengarten J., Ott H.: Paediatric lichen sclerosus: a systematic review of 4516 cases. Br J Dermatol 2020, 182, 231-233.

7 

Dinh H., Purcell S.M., Chung C., Zaenglein A.L.: Pediatric lichen sclerosus: a review of the literature and management recommendations. J Clin Aesthet Dermatol 2016, 9, 49-54.

8 

Purres J., Krull E.A.: Lichen sclerosus et atrophicus involving the palms. Arch Dermatol 1971, 104, 68-69.

9 

Petrozzi J.W., Wood M.G., Tisa V.: Palmar-plantar lichen sclerosus et atrophicus. Arch Dermatol 1979, 115, 884.

10 

Steff M., Toulemonde A., Croue A., Lemerle E., Le Corre Y., Verret J.L.: Lichen scléreux acral [Acral lichen sclerosus et atrophicus]. Ann Dermatol Venereol 2008, 135, 201-204.

11 

De Viana F.O., Cavaleiro L.H., Unger D.A., Miranda M.F., Brito A.C.: Acral lichen sclerosus et atrophicus--case report. An Bras Dermatol 2011, 86 (4 Suppl 1), S82-S84.

12 

Herz-Ruelas M.E., Barboza-Quintana O., Cuéllar-Barboza A., Cárdenas-de la Garza J.A., Gómez-Flores M.: Acral bullous lichen sclerosus intolerant to UVA-1 successfully treated with narrowband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed 2019, 35, 378-380.

13 

Seyffert J., Bibliowicz N., Harding T., Nathoo R., Saeed S.: Palmar lichen sclerosus et atrophicus. JAAD Case Rep 2020, 6, 697-699.

14 

Sánchez-Mateos D.S., Jo-Velasco M., Alegría-Landa V., Del Carmen Fariña-Sabaris M., Requena L.: Acrolocalized variant of lichen sclerosus initially manifesting as degenerative collagenous plaques of the hands. J Cutan Pathol 2020, 47, 269-274.

15 

Heibel H.D., Styles A.R., Cockerell C.J.: A case of acral lichen sclerosus et atrophicus. JAAD Case Rep 2020, 8, 26-27.

16 

Aggarwal K., Jain V.K., Brahma D.: Palmo-plantar lichen sclerosus et atrophicus. Indian J Dermatol Venereol Leprol 2003, 69, 43-44.

17 

Murphy R.: Lichen sclerosus. Dermatol Clin 2010, 28, 707-715.

18 

Maronn M.L., Esterly N.B.: Constipation as a feature of anogenital lichen sclerosus in children. Pediatrics 2005, 115, e230-e232.

19 

Jensen L.S., Bygum A.: Childhood lichen sclerosus is a rare but important diagnosis. Dan Med J 2012, 59, A4424.

20 

Powell J., Wojnarowska F.: Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001, 44, 803-806.

21 

Meffert J.J., Davies B.M., Grimwood R.E.: Lichen sclerosus. J Am Acad Dermatol 1995, 32, 393-416.

22 

Powell J., Wojnarowska F., Winsey S., Marren P., Welsh K.: Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000, 142, 481-484.

23 

Orszulak D., Dulska A., Niziński K., Skowronek K., Bodziony J., Stojko R., et al.:. Pediatric vulvar lichen sclerosus-a review of the literature. Int J Environ Res Public Health 2021, 18, 7153.

24 

Warrington S.A., de San Lazaro C.: Lichen sclerosus et atrophicus and sexual abuse. Arch Dis Child 1996, 75, 512-516.

25 

Dodeja A., Karani H., Pande S.: Morphea and extragenital lichen sclerosus et atrophicus overlap. Cureus 2024, 16, e71176.

26 

Prasanna S., Haridas N.S., Kharkar V., Khade P.: Extragenital lichen sclerosus et atrophicus-morphea overlap masquerading as lupus vulgaris: histopathology to the rescue. Dermatol Pract Concept 2023, 13, e2023141.

27 

Fistarol S.K., Itin P.H.: Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol 2013, 14, 27-47.

28 

D’Souza S.L., Ravikumar G., Antony M., Tirumale R.: Vulvar lichenoid dermatoses with emphasis on the distinction between lichen sclerosus and lichen planus: a 10-year study. J Low Genit Tract Dis 2024, 28, 189-197.

29 

Attili V.R., Attili S.K.: Acral vitiligo and lichen sclerosus – association or a distinct pattern? A clinical and histopathological review of 15 cases. Indian J Dermatol 2015, 60, 519.

30 

Park Y.J., Lee H., Park H.S., Kim Y.C.: Histopathological differences between vitiligo and lichen sclerosus et atrophicus using quantitative immunohistochemical analysis. Front Med 2023, 10, 1205909.

Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
© 2026 Termedia Sp. z o.o.
Developed by Termedia.